Borte, Michael
Melamed, Isaac R.
Pulka, Grazyna
Pyringer, Barbara
Knutsen, Alan P.
Ochs, Hans D.
Kobayashi, Roger H.
Kobayashi, Ai Lan
Gupta, Sudhir
Strach, Magdalena
Smits, William
Pituch-Noworolska, Anna
Moy, James N.
Article History
Received: 14 March 2017
Accepted: 18 July 2017
First Online: 29 July 2017
Compliance with Ethical Standards
:
: M Borte’s institution has received research grant support from CSL Behring, Octapharma, and Baxalta, and he has participated in advisory boards for CSL Behring and Octapharma. IR Melamed has received research grant support from CSL Behring, Octapharma, Baxalta, and Bio Products Laboratories. B. Pyringer is an employee of Octapharma, Vienna, Austria. AP Knutsen has acted as a consultant for Baxalta, CSL, and Octapharma. HD Ochs has acted as consultant for Baxalta, CSL Behring, and Octapharma. RH Kobayashi has acted as a consultant for Baxalta, CSL, ADMA, and Octapharma. AL Kobayashi received grant support from Baxalta and Octapharma. JN Moy has received fees as a consultant for Grifols, Prometic, Octapharma, MacroCure, and Baxalta. G Pulka, S Gupta, M Strach, W Smits, and A Pituch-Noworolska have no conflicts of interest to declare. Open Access for this Article was funded by Octapharma.